54 Biggest Movers From Thursday
Gainers
22nd Century Group, Inc. (NASDAQ: XXII) surged 38.6% to settle at $3.05. The FDA authorized marketing of tobacco products that help reduce exposure to and consumption of nicotine for smokers who use them.
Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell
• LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
Preview: HTG Molecular Diagnostics’s Earnings
HTG Molecular Diagnostics (NASDAQ:HTGM) is set to give its latest quarterly earnings report on Wednesday, 2021-11-10. Here's what investors need to know before the announcement.
Analysts estimate that HTG Molecular Diagnostics will likely report an Earnings Per Share (EPS) of $-0.66
HTG Molecular Diagnostics’s Return On Capital Employed Insights
According to Benzinga Pro data, during Q2, HTG Molecular Diagnostics (NASDAQ:HTGM) posted sales of $2.07 million. Earnings were up 10.91%, but HTG Molecular Diagnostics still reported an overall loss of $4.08 million.
HTG Molecular Diagnostics Q2 EPS $(0.39) Beats $(0.77) Estimate, Sales $2.10M Miss $2.13M Estimate
HTG Molecular Diagnostics (NASDAQ:HTGM) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.77) by 49.35 percent. This is a 333.33 percent decrease over losses of $(0.09) per
Earnings Scheduled For August 12, 2021
Companies Reporting Before The Bell
• Anavex Life Sciences (NASDAQ:AVXL) is estimated to report earnings for its third quarter.
HTG’s New HTG Transcriptome Panel Launched with Commercial Availability in the U.S. and Europe
HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the commercial launch and immediate availability of its HTG Transcriptome Panel,